Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases

Author： Hashimoto Makoto   Rockenstein Edward   Crews Leslie   Masliah Eliezer  

Publisher： Humana Press, Inc

ISSN： 1535-1084

Source： NeuroMolecular Medicine, Vol.4, Iss.1-2, 2003-10, pp. : 21-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease

By Liu Jiankang   Ames Bruce N.  

Nutritional Neuroscience, Vol. 8, Iss. 2, 2005-04 ,pp. : 67-89

Maney Publishing

Access to resources Recommend Favorite

Mitochondrial Dysfunction and Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 3, Iss. 5, 2006-12 ,pp. : 515-520

Bentham Science Publishers

Access to resources Recommend Favorite

Parkinson’s and Alzheimer’s diseases: Protein aggregations and neuroprotection

By Gozes Illana  

Journal of Molecular Neuroscience, Vol. 24, Iss. 3, 2004-10 ,pp. : 333-336

Humana Press, Inc

Access to resources Recommend Favorite

Parkinson's disease, pesticides and mitochondrial dysfunction

By Jenner P.  

Trends in Neurosciences, Vol. 24, Iss. 5, 2001-05 ,pp. : 245-246

Elsevier

Access to resources Recommend Favorite

Assessment of the Efficacy of Solutes from Extremophiles on Protein Aggregation in Cell Models of Huntington’s and Parkinson’s Diseases

By Jorge Carla   Ventura Rita   Maycock Christopher   Outeiro Tiago   Santos Helena   Costa Júlia  

Neurochemical Research, Vol. 36, Iss. 6, 2011-06 ,pp. : 1005-1011

Springer Publishing Company

Access to resources Recommend Favorite